-
Trump: Fannie Mae, Freddie Mac Need to 'Get Big Homebuilders Going'
President Donald Trump on Sunday urged U.S. mortgage financing companies Fannie Mae and Freddie Mac to "get Big Homebuilders going," saying without providing evidence that U.S. builders were "sitting on 2 Million empty lots, a RECORD."
-
Magnificent 7 Still Shape Future, as New Macro Is Micro
Every few years, markets ask whether the leading companies of the age have peaked. Today, that question hovers over the Magnificent Seven - the group of mega-cap tech firms that have powered much of the equity market's returns.
-
3 Water Stocks for Long-Term Dividend Growth
Water is one of the most vital components of life. It is natural for investors to include water stocks in their portfolios. In general, water stocks have simple business models and are resilient to recessions thanks to the essential nature of their business.
-
No Payrolls, No Problem as Global Stocks Hit Record Highs
World stocks were on course for a solid weekly gain and more record highs, as the seemingly unstoppable rally in tech shares and expectations of lower U.S. interest rates helped offset U.S. government shutdown uncertainty.
-
Trump: Tariffs Could Mean $2K Dividend for Americans
As the country awaits a Supreme Court ruling on the legality of Donald Trump's global tariffs, the president said he's considering paying Americans a dividend with the revenue.
-
2025 Chevrolet Silverado Trail Boss Diesel
A Rugged Powerhouse With Modern Flair
-
30-Year Mortgage Rate Ticks up to 6.34%
The average rate on a 30-year U.S. mortgage ticked up for the second straight week following a string of declines that had brought down home borrowing costs to their lowest level in nearly a year.
-
Sen. Marshall to Newsmax: TrumpRx Is Going to Drive Down Drug Prices
On Tuesday, President Donald Trump announced several initiatives intended to lower drug costs in the United States. These include launching a "TrumpRx" direct-to-consumer website that offers medicines at reduced prices and reaching an agreement with Pfizer to decrease the...
-
Apple Pauses Vision Pro Overhaul to Bet on AI Glasses
Apple has halted a planned overhaul of its Vision Pro mixed-reality headset to shift resources to smart glasses that would rival products from Meta Platforms, Bloomberg News reported, citing people familiar with the matter.
-
Gold Hits New Record Just Under $3,900
Gold prices rose to hit a new record high Wednesday, supported by safe-haven demand as the U.S. government shut down most operations, while growing expectations of a Federal Reserve rate cut this month added to the metal's appeal.
-
2026 Genesis GV70 Review: A Luxury SUV That Outshines the BMW X3?
The 2026 Genesis GV70 is a compact luxury SUV that blends style, performance, and value, making it a formidable contender against the BMW X3 and other rivals like the Audi Q5 and Mercedes-Benz GLC.
-
Walmart to Remove Synthetic Dyes From Its Food Brands
Walmart said Wednesday it would remove synthetic dyes from its U.S. store-brand food products, including Great Value and bettergoods, by January 2027.
-
Markets in Third Quarter: The Calm After the Storm
After the storms earlier in the year, investors have basked in a steamy summer market melt-up that has added another $5 trillion to record-high share markets and lifted almost everything else, too.
-
US Auto Sales Set to Rise 6% in Third Quarter
U.S. auto sales are expected to rise about 6% in the third quarter from a year ago, as consumers were seen pulling forward their electric vehicle purchases before the end of certain tax credits, while demand for SUVs and crossovers remained steady.
-
Big Pharma Firms Announce Direct-to-Consumer Sales and Price Cuts
Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts following President Donald Trump's calls to bring down drug prices and cut out "middlemen" like pharmacies, insurers and pharmacy benefit managers.
-
Amazon Refreshes Alexa+ AI, Home Security Devices
Amazon Tuesday unveiled a refreshed lineup of devices optimized for home security and its new artificial intelligence-infused Alexa+ voice assistant.
-
LifeMD to Sell Ozempic in US at $499 Cash a Month
Telehealth firm LifeMD said on Tuesday it would partner with Novo Nordisk to offer its diabetes drug Ozempic at $499 per month to eligible U.S. patients, including insured people whose plans do not cover GLP-1 therapies. Novo offers Ozempic for $499 a month to eligible...
-
Home Remodeling Costs Outpace Inflation in Q2
If it seems like its getting more expensive to replace a broken door, kitchen fixtures or upgrade a major appliance, you're not wrong.
-
Social Security Payouts Should Continue During Shutdown
Social Security payouts are expected to continue going out normally, despite a potential federal government shutdown on Wednesday.
-
Pending Home Sales Rebound Amid Low Mortgages
Sales of previously owned U.S. homes increased solidly in August as lower mortgage rates pulled buyers back into the market, though a softening labor market could curb further gains.
-
Pharma Group to Launch Direct-to-Consumer Website
U.S. pharmaceutical lobby group PhRMA said on Monday it would launch a new website in January to help patients buy prescription drugs directly from manufacturers, bypassing pharmacy benefit managers and other middlemen. The site, to be called AmericasMedicines.com, will...
-
Goldman Upgrades Global Equities on Growth Optimism
Goldman Sachs Monday upgraded its stance on global equities to "overweight" from "neutral" over the three-month horizon, citing improving economic momentum across regions, attractive valuations and growing support from monetary and fiscal policy.
-
SEC Paves the Way for ETFs in Mutual Funds
The U.S. Securities and Exchange Commission Monday paved the way for an asset manager to add exchange-traded share classes to mutual funds, a move expected to kick-start approvals for dozens of applicants, spark more ETFs and make the products more accessible to retail...
-
Slowdown Signals: Are Leading Indicators Flashing Red?
Lately, there's been a growing sense of confidence among investors that the U.S. economy has dodged the proverbial bullet. Despite a historic rate-hiking cycle by the Federal Reserve, two years of stubborn inflation, and signs of strain in global trade, the dominant Wall...
-
OpenAI to Bring Parental Controls to ChatGPT After California Teen's Suicide
OpenAI is rolling out parental controls for ChatGPT on the web and mobile, following a lawsuit by the parents of a teen who died by suicide after the artificial intelligence startup's chatbot allegedly coached him on methods of self-harm.